09/17/2026
There is no FDA-approved testosterone product for women in the United States. Not one.
Women produce testosterone throughout life, and those levels decline with age. It’s still treated as a men’s health topic, and the women asking about it usually get waved off.
What happens instead is a workaround. Clinicians prescribe products approved for men, off-label and adjusted, or turn to compounded versions. That’s a gap, and women are the ones living inside it. A global consensus statement endorsed by more than a dozen major medical societies, including the Endocrine Society and the International Menopause Society, called for products to be developed and licensed for women and for more research to be funded. The holdup isn’t science. It’s incentive. Australia has an approved option. American women don’t.
Let me be honest about the evidence too. That same consensus found the data strongest for one specific indication in postmenopausal women, and still insufficient for the broader symptom picture. That isn’t a reason to dismiss women. It’s a reason to close the gap.
Which is why PepMed 2026 matters. The Regenerative Health World Congress is happening right now in Washington, DC, with physicians, pharmacists, researchers, and legislators in one room and a sitting member of Congress, Rep. Diana Harshbarger, delivering the keynote. Terri DeNeui, DNP, APRN, ACNP-BC is speaking there on hormone health in women. These conversations are finally happening on the record, in the room where policy actually gets made.
💬 Comment HORMONE and I’ll send you my free guide to hormone health in women. Want to talk through your own hormone health? Book a session with me or our coaching team through the link in bio.
Amber Cameneti, FNP-C
Board-Certified Family Nurse Practitioner
Educational purposes only. Not medical advice. Requires physician oversight. Individual results vary.